这是一篇来自已证抗体库的有关
人类 PIK3CB的综述,是根据15篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PIK3CB 抗体。
PIK3CB 同义词: P110BETA; PI3K; PI3KBETA; PIK3C1
圣克鲁斯生物技术
小鼠 单克隆(B-5) | | 圣克鲁斯生物技术 PIK3CB抗体(SantaCruz, sc-376412)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi |
小鼠 单克隆(D-2) | | 圣克鲁斯生物技术 PIK3CB抗体(Santa Cruz, sc-376492)被用于被用于免疫印迹在小鼠样本上 (图 2a). Cell Signal (2016) ncbi |
小鼠 单克隆(D-4) | | 圣克鲁斯生物技术 PIK3CB抗体(Santa Cruz Biotechnology Inc, sc-8010)被用于被用于免疫印迹在人类样本上浓度为1:200. PLoS ONE (2014) ncbi |
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(EPR5515(2)) | | 艾博抗(上海)贸易有限公司 PIK3CB抗体(Abcam, ab151549)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5b). Biosci Rep (2019) ncbi |
domestic rabbit 单克隆(EPR5515(2)) | | 艾博抗(上海)贸易有限公司 PIK3CB抗体(Abcam, ab151549)被用于被用于免疫印迹在大鼠样本上 (图 5d). Oxid Med Cell Longev (2017) ncbi |
domestic rabbit 单克隆(EPR5515(2)) | | 艾博抗(上海)贸易有限公司 PIK3CB抗体(Abcam, ab151549)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 4). Biochem J (2016) ncbi |
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(C33D4) | | 赛信通(上海)生物试剂有限公司 PIK3CB抗体(CST, 3011)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). J Cancer (2021) ncbi |
domestic rabbit 单克隆(C33D4) | | 赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, 3011)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1a). Nat Commun (2019) ncbi |
domestic rabbit 单克隆(C33D4) | | 赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell signaling, 3011s)被用于被用于免疫印迹在人类样本上 (图 6a). Cancer Med (2017) ncbi |
domestic rabbit 单克隆(C33D4) | | 赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, C33D4)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6c). Nat Commun (2016) ncbi |
domestic rabbit 单克隆(C33D4) | | 赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, 3011)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 1). elife (2016) ncbi |
domestic rabbit 单克隆(C33D4) | | 赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, 3011)被用于被用于免疫印迹在人类样本上 (图 s1). Cell Discov (2016) ncbi |
domestic rabbit 单克隆(C33D4) | | 赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, C33D4)被用于被用于免疫印迹在人类样本上 (图 4c). Oncotarget (2016) ncbi |
domestic rabbit 单克隆(C33D4) | | 赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, 3011)被用于被用于免疫印迹在人类样本上 (图 4). Oncotarget (2016) ncbi |
domestic rabbit 单克隆(C33D4) | | 赛信通(上海)生物试剂有限公司 PIK3CB抗体(Cell Signaling, C33D4)被用于被用于免疫印迹在人类样本上. Mol Cell Biol (2014) ncbi |
Lin G, Li J, Cai J, Zhang H, Xin Q, Wang N,
et al. RNA-binding Protein MBNL2 regulates Cancer Cell Metastasis through MiR-182-MBNL2-AKT Pathway. J Cancer. 2021;12:6715-6726
pubmed 出版商
You Y, Qin Z, Zhang H, Yuan Z, Yu X. MicroRNA-153 promotes brain-derived neurotrophic factor and hippocampal neuron proliferation to alleviate autism symptoms through inhibition of JAK-STAT pathway by LEPR. Biosci Rep. 2019;:
pubmed 出版商
Araiz C, Yan A, Bettedi L, Samuelson I, Virtue S, McGavigan A,
et al. Enhanced β-adrenergic signalling underlies an age-dependent beneficial metabolic effect of PI3K p110α inactivation in adipose tissue. Nat Commun. 2019;10:1546
pubmed 出版商
Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y,
et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10
pubmed 出版商
Gomes J, Fernandes T, Soci U, Silveira A, Barretti D, Negrao C,
et al. Obesity Downregulates MicroRNA-126 Inducing Capillary Rarefaction in Skeletal Muscle: Effects of Aerobic Exercise Training. Oxid Med Cell Longev. 2017;2017:2415246
pubmed 出版商
Liu S, Gao G, Yan D, Chen X, Yao X, Guo S,
et al. Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways. Cancer Med. 2017;6:819-833
pubmed 出版商
Yang J, Savvatis K, Kang J, Fan P, Zhong H, Schwartz K,
et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat Commun. 2016;7:13710
pubmed 出版商
Cizmecioglu O, Ni J, Xie S, Zhao J, Roberts T. Rac1-mediated membrane raft localization of PI3K/p110? is required for its activation by GPCRs or PTEN loss. elife. 2016;5:
pubmed 出版商
Yuzugullu H, Von T, Thorpe L, Walker S, Roberts T, Frank D,
et al. NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K-AKT and JAK-STAT3 pathways. Cell Discov. 2016;2:16030
pubmed 出版商
Jacobsen R, Mazloumi Gavgani F, Mellgren G, Lewis A. DNA Topoisomerase II? contributes to the early steps of adipogenesis in 3T3-L1 cells. Cell Signal. 2016;28:1593-603
pubmed 出版商
Monica V, Lo Iacono M, Bracco E, Busso S, di Blasio L, Primo L,
et al. Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines. Oncotarget. 2016;7:76577-76589
pubmed 出版商
Karlsson T, Altankhuyag A, Dobrovolska O, Turcu D, Lewis A. A polybasic motif in ErbB3-binding protein 1 (EBP1) has key functions in nucleolar localization and polyphosphoinositide interaction. Biochem J. 2016;473:2033-47
pubmed 出版商
Lynch J, McEwen R, Crafter C, McDermott U, Garnett M, Barry S,
et al. Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen. Oncotarget. 2016;7:22128-39
pubmed 出版商
Parenti R, Cardile V, Graziano A, Parenti C, Venuti A, Bertuccio M,
et al. Wilms' tumor gene 1 (WT1) silencing inhibits proliferation of malignant peripheral nerve sheath tumor sNF96.2 cell line. PLoS ONE. 2014;9:e114333
pubmed 出版商
Perez García V, Redondo Muñoz J, Kumar A, Carrera A. Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity. Mol Cell Biol. 2014;34:3359-73
pubmed 出版商